PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

84 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
41.
Manz, J. et al.: Targeted resequencing and functional testing identifies low-frequency missense variants in the gene encoding GARP as significant contributors to atopic dermatitis risk. J. Invest. Dermatol. 136, 2380-2386 (2016)
42.
Musiol, S. et al.: The Ying & Yang of IL23p40 in psoriatic plaque formation. J. Invest. Dermatol. 136, S261-S261 (2016)
43.
Russkamp, D. et al.: Alum-free thermosensitive hydrogel as subcutaneous matrix for immunomodulators and allergens during specific immunotherapy. J. Invest. Dermatol. 136, 2, S231-S231 (2016)
44.
Schlumprecht, C. et al.: Immuno-modulatory effects of pre-/probiotics and active microbial structures on human primary keratinocytes. J. Invest. Dermatol. 136, S208-S208 (2016)
45.
Standl, M. et al.: Association of atopic dermatitis with cardiometabolic diseases and risk factor. J. Invest. Dermatol. 136, S165-S165 (2016)
46.
Wang, R.* et al.: Cellular mechanism of action of IgE-specific immunoadsorption in treatment of patients with severe atopic eczema. J. Invest. Dermatol. 136, S168-S168 (2016)
47.
Wimmer, M. et al.: Pollen-derived adenosine plays an important role in induction of ragweed allerg. J. Invest. Dermatol. 136, S229-S229 (2016)
48.
Avitabile, S.* et al.: Interleukin-22 promotes wound repair in diabetes by improving keratinocyte pro-healing functions. J. Invest. Dermatol. 135, 2862-2870 (2015)
49.
Baurecht, H.* et al.: Epidemiologic and genetic association between atopic dermatitis, rheumatoid arthritis, inflammatory bowel disease, and type-1 diabetes. J. Invest. Dermatol. 135, S63 (2015)
50.
Brosch, S.* et al.: Disease control in cutaneous leishmaniasis is independent of IL-22. J. Invest. Dermatol. 135, 308-311 (2015)
51.
Fukunaga-Kalabis, M.* et al.: MSX1-induced neural crest-like reprograming promotes melanoma progression. J. Invest. Dermatol. 135, S111 (2015)
52.
Garzorz, N.V.* et al.: Molecular diagnostics of psoriasis and eczema-a novel approach to establish personalised therapy. J. Invest. Dermatol. 135, S1 (2015)
53.
Koch, M.* et al.: Psoriasis and cardiometabolic traits: Modest association but distinct genetic architectures. J. Invest. Dermatol. 135, 1283-1293 (2015)
54.
Paternoster, L.* ; Standl, M. ; Baurecht, H.* ; Evans, D.M* & Weidinger, S.*: Multi-ethnic genome-wide association study of 21,000 cases and 95,000 controls identifies 11 novel risk loci for atopic dermatitis. J. Invest. Dermatol. 135, S56 (2015)
55.
Rodriguez, E.* et al.: Targeted resequencing and finemapping identifies functional low-frequency missense variants in LRRC32 as risk factors for atopic dermatitis. J. Invest. Dermatol. 135, S58 (2015)
56.
Garzorz, N.V.* et al.: Intra-individual genome expression analysis reveals a specific molecular signature of psoriasis and eczema. J. Invest. Dermatol. 134, S1 (2014)
57.
Kretschmer, A. et al.: A common atopy-associated variant in the Th2 cytokine locus control region impacts transcriptional regulation and alters SMAD3 and SP1 binding. J. Invest. Dermatol. 134, S55 (2014)
58.
Röck, K.* et al.: miR-23a-3p causes cellular senescence by targeting hyaluronan synthase2: Possible implication for skin aging. J. Invest. Dermatol. 135, 369-377 (2014)
59.
Rodriguez, E.* et al.: An integrated epigenetic and transcriptomic analysis reveals distinct tissue-specific patterns of DNA methylation associated with atopic dermatitis. J. Invest. Dermatol. 134, 1873-1883 (2014)
60.
Deo, M.* ; Huang, J. L.-Y.* ; Fuchs, H. ; Hrabě de Angelis, M. & van Raamsdonk, C. D.*: Differential effects of neurofibromin gene dosage on melanocyte development. J. Invest. Dermatol. 133, 49-58 (2013)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... ▶▶ ▶▮